Boehringer launches 81% discounted biosimilar of AbbVie’s Humira

[ad_1] The logo of German pharmaceutical company Boehringer Ingelheim is seen at its building in Shanghai, China February 1, 2019. REUTERS/Stringer/File Photo Acquire Licensing Rights Oct 2 (Reuters) – Germany’s…

Blood thinners, diabetes meds among first 10 drugs for US price negotiations

[ad_1] Aug 29(Reuters) – The Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health…